Table 1.
All Patients Baseline Characteristics
| Demographic: | N=1385 | |||||
|---|---|---|---|---|---|---|
| Age | ||||||
| Mean | 63.18 | |||||
| Median (Range) | 64 (29-87) | |||||
|
| ||||||
| Gender | ||||||
| Male no. (%) | 735 (53.1) | |||||
|
| ||||||
| Race | ||||||
| White | 1231 (89.8) | |||||
| Other | 140 (10.2) | |||||
| Missing | 14 | |||||
|
| ||||||
| Treatment Characteristics: | ||||||
|
| ||||||
| Facility Type | ||||||
| CCP | 192 (13.9) | |||||
| CCCP | 697 (50.3) | |||||
| ARCP | 496 (35.8) | |||||
|
| ||||||
| Radiation Dose (Gy) | Radiation Dose Category (Gy) | |||||
| Mean | 45.21 | < 40 | 164 (11.8) | |||
| Median | 45 | ≥ 40 - < 50 | 634 (45.8) | |||
| Range | 1.63 - 69 | ≥ 50 - < 55 | 498 (36.0) | |||
| ≥ 55 | 89 (6.4) | |||||
|
| ||||||
| Radiation Duration (days) | ||||||
| Mean | 40.18 | |||||
| Median (Range) | 39 (1-100) | |||||
| Missing | 695 | |||||
|
| ||||||
| Concurrent Chemotherapy | ||||||
| Yes | 1265 (92.1) | |||||
| No | 108 (7.9) | |||||
| Missing | 12 | |||||
|
| ||||||
|
Tumor Characteristics:
|
||||||
| Stage (AJCC 5th) | ||||||
| I | 231 (16.9) | |||||
| II | 273 (20.0) | |||||
| III | 734 (53.8) | |||||
| IVA | 126 (9.3) | |||||
| Missing | 21 | |||||
|
| ||||||
| Tumor Size (mm) | Size Groupings (mm) | |||||
| Mean | 35.88 | ≤20 | 269 (21.6) | |||
| Median (Range) | 30.0 (1-750) | >20 - ≤ 30 | 399 (32.0) | |||
| >30 - ≤ 40 | 304 (24.4) | |||||
| >40 | 274 (22.0) | |||||
| Missing | 139 | |||||
|
| ||||||
| Number of LN’s Examined | LN Positive | |||||
| Mean | 9.75 | Yes | 800 (61.7) | |||
| Median (Range) | 8 (0-60) | No | 497 (38.3) | |||
| Missing | 100 | Missing | 88 | |||
|
| ||||||
| Histologic Grade | ||||||
| Unspecified | 113 (8.2) | |||||
| I | 165 (11.9) | |||||
| II | 655 (47.3) | |||||
| III/IV | 452 (32.6) | |||||
|
| ||||||
| Margin | ||||||
| Negative | 899 (71.3) | |||||
| Positive | 361 (28.7) | |||||
| Missing | 125 | |||||
Gy- Gray, LN- Lymph node, CCP-Community Cancer Program, CCCP- Comprehensive Community Cancer Programs, ARCP- Academic Research Cancer Program, LN- Lymph nodes AJCC-American Joint Committee on Cancer, no.- Number